Koda N et al. |
Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. |
2004 |
Arch. Biochem. Biophys. |
pmid:15047184
|
Mueller C et al. |
Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. |
2003 |
Arch. Biochem. Biophys. |
pmid:14522590
|
Morii H and Watanabe Y |
A possible role of carbohydrate moieties in prostaglandin D2 and prostaglandin E2 receptor proteins from the porcine temporal cortex. |
1992 |
Arch. Biochem. Biophys. |
pmid:1309289
|
Morrow JD et al. |
Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione. |
1998 |
Arch. Biochem. Biophys. |
pmid:9578611
|
Ujihara M et al. |
Biochemical and immunological demonstration of prostaglandin D2, E2, and F2 alpha formation from prostaglandin H2 by various rat glutathione S-transferase isozymes. |
1988 |
Arch. Biochem. Biophys. |
pmid:3041912
|
Oyama S et al. |
A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells. |
2014 |
Arch. Biochem. Biophys. |
pmid:24239863
|
Grunnet N et al. |
Absence of glycogen cycling in cultured rat hepatocytes. |
1994 |
Arch. Biochem. Biophys. |
pmid:8117107
|
Kitatani K et al. |
Ceramide accelerates dephosphorylation of extracellular signal-regulated kinase 1/2 to decrease prostaglandin D(2) production in RBL-2H3 cells. |
2001 |
Arch. Biochem. Biophys. |
pmid:11697858
|
Ujihara M et al. |
Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. |
1988 |
Arch. Biochem. Biophys. |
pmid:3124755
|
Ikai K and Fukushima M |
Effects of cytotoxic prostaglandin, delta 12-PGJ2 on protein synthesis and cytoskeleton in transformed epidermal cells in culture. |
1990 |
Arch. Dermatol. Res. |
pmid:1693839
|
Saarinen JV et al. |
Release of histamine and leukotriene C4 in immediate allergic wheal reaction as measured with the microdialysis technique. |
2000 |
Arch. Dermatol. Res. |
pmid:10966057
|
Steinbrink K et al. |
Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins. |
2000 |
Arch. Dermatol. Res. |
pmid:11000287
|
Zhang GY et al. |
Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. |
2009 |
Arch. Dermatol. Res. |
pmid:19466435
|
Furutani K et al. |
Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro. |
1999 Jul-Aug |
Arch. Dermatol. Res. |
pmid:10482019
|
Ikai K et al. |
Ear swelling in response to UVB irradiation. |
1986 |
Arch. Dermatol. Res. |
pmid:3466577
|
Kang HY et al. |
Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis. |
2006 |
Arch. Dermatol. Res. |
pmid:16474974
|
Nittner-Marszalska M et al. |
9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients. |
2015 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:25763689
|
Kolaczkowska E et al. |
Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation. |
2009 Nov-Dec |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:19885646
|
Brown MS et al. |
Arachidonic acid metabolites during nasal challenge. |
1987 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:3099812
|
Kim SJ et al. |
Effects of methyl gallate on arachidonic acid metabolizing enzymes: Cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. |
2006 |
Arch. Pharm. Res. |
pmid:17121182
|
Son MJ et al. |
Naturally occurring biflavonoid, ochnaflavone, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. |
2006 |
Arch. Pharm. Res. |
pmid:16681032
|
Hwang GS et al. |
Effects of Brazilin on the phospholipase A2 activity and changes of intracellular free calcium concentration in rat platelets. |
1998 |
Arch. Pharm. Res. |
pmid:9868555
|
Choi YH et al. |
New anti-inflammatory formulation containing Synurus deltoides extract. |
2005 |
Arch. Pharm. Res. |
pmid:16114500
|
Yang JH et al. |
Anti-allergic activity of an ethanol extract from Salviae miltiorrhiza. |
2008 |
Arch. Pharm. Res. |
pmid:19099230
|
Jin M et al. |
Anti-inflammatory activity of 6-hydroxy-2,7-dimethoxy-1,4-henanthraquinone from tuberous roots of yam (Dioscorea batatas) through inhibition of prostaglandin Dâ‚‚ and leukotriene Câ‚„ production in mouse bone marrow-derived mast cells. |
2011 |
Arch. Pharm. Res. |
pmid:21975811
|
Lee JJ et al. |
The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. |
2010 |
Arch. Pharm. Res. |
pmid:20361303
|
Zheng MS et al. |
Chemical constituents of Melandrium firmum Rohrbach and their anti-inflammatory activity. |
2008 |
Arch. Pharm. Res. |
pmid:18409044
|
Moon TC et al. |
The effects of isoimperatorin isolated from Angelicae dahuricae on cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. |
2008 |
Arch. Pharm. Res. |
pmid:18365692
|
Lee CH and Edwards AM |
Differential expression of c-fos and c-myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes. |
2003 |
Arch. Toxicol. |
pmid:12632255
|
Nakajima N et al. |
[Alternation of ion transport of airway epithelium by eicosanoids]. |
2005 |
Arerugi |
pmid:16407682
|
Nagai H |
[The role of lipid mediators in allergic diseases]. |
2007 |
Arerugi |
pmid:17615500
|
Itoh Y et al. |
[Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi]. |
1993 |
Arerugi |
pmid:8279967
|
Buga GM et al. |
L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19965777
|
Kobayashi K et al. |
Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway. |
2013 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:23307871
|
Lin TN et al. |
15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. |
2006 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16385084
|
Hatoum OA et al. |
Novel mechanism of vasodilation in inflammatory bowel disease. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16141408
|
Polikandriotis JA et al. |
Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16020752
|
Migita H and Morser J |
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15662020
|
Marx N et al. |
PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. |
1999 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:10073956
|
Jackson SM et al. |
Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. |
1999 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:10479650
|
Hofnagel O et al. |
Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15271788
|
Abe M et al. |
GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12615657
|
Levonen AL et al. |
Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. |
2001 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11701476
|
King VL et al. |
Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. |
2006 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16514081
|
Cipollone F et al. |
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15155382
|
Calnek DS et al. |
Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12524224
|
Jung SM et al. |
Reduction of urate crystal-induced inflammation by root extracts from traditional oriental medicinal plants: elevation of prostaglandin D2 levels. |
2007 |
Arthritis Res. Ther. |
pmid:17612394
|
Ulivi V et al. |
Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway. |
2011 |
Arthritis Res. Ther. |
pmid:21682897
|
Bianchi A et al. |
Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2. |
2005 |
Arthritis Res. Ther. |
pmid:16277686
|
Farrajota K et al. |
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15641079
|